China Resources Pharmaceutical Group
3320.HK
#3002
Rank
ยฃ3.39 B
Marketcap
ยฃ0.54
Share price
0.00%
Change (1 day)
10.52%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2022: ยฃ26.15 Billion

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is ยฃ26.15 Billion. In 2022 the company made a revenue of ยฃ26.15 Billion an increase over the revenue in the year 2021 that were of ยฃ24.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2013 to 2022

Annual revenue

Year Revenue Change
2022ยฃ26.15 B7.09%
2021ยฃ24.42 B17.47%
2020ยฃ20.79 B-1.52%
2019ยฃ21.11 B8.38%
2018ยฃ19.48 B9.69%
2017ยฃ17.76 B9.28%
2016ยฃ16.25 B6.86%
2015ยฃ15.20 B8.05%
2014ยฃ14.07 B16.04%
2013ยฃ12.12 B